Bernardi Daniele, Barzan Luigi, Franchin Giovanni, Cinelli Roberta, Balestreri Luca, Tirelli Umberto, Vaccher Emanuela
Division of Medical Oncology A, National Cancer Institute, Aviano (PN), Italy.
Crit Rev Oncol Hematol. 2005 Jan;53(1):71-80. doi: 10.1016/j.critrevonc.2004.08.001.
Although the majority of head and neck cancers occur between the fifth and sixth decade, their onset in patients older than 60 years is not a rare event. A peculiar characteristic of almost all case series is the lower prevalence of radical treatments among elderly as compared to younger patients, in particular surgery and combined treatment of surgery plus radiation therapy or chemotherapy and radiation therapy. Radiotherapy is a feasible treatment in elderly patients, also in very advanced age groups and, in the era of organ preservation, chemotherapy combined with RT has a paramount importance. Therapeutical planning must be based not only on tumor characteristics, but also on the physiological, rather than the chronological age the patient. The main clinical problem is, therefore, the selection of patients to be administered anticancer treatment. In patients aged 70 or older, complete geriatric assessment and a multidisciplinary approach are the crucial points.
尽管大多数头颈癌发生在50至60岁之间,但在60岁以上患者中发病并非罕见。几乎所有病例系列的一个特殊特征是,与年轻患者相比,老年患者接受根治性治疗的比例较低,尤其是手术以及手术加放疗或化疗加放疗的联合治疗。放疗对老年患者是一种可行的治疗方法,即使是在年龄非常大的人群中也是如此,并且在器官保留时代,化疗联合放疗至关重要。治疗计划不仅必须基于肿瘤特征,还必须基于患者的生理年龄而非实际年龄。因此,主要的临床问题是选择接受抗癌治疗的患者。对于70岁及以上的患者,全面的老年评估和多学科方法是关键要点。